Regenerative Medicine Market Is Anticipated To Grow Quickly Due To Rising Prevalence Of Complicated Degenerative Disorders Till 2025: Grand View Research, Inc.
The global regenerative medicine market size is expected to
reach USD 5.59 billion by 2025, according to a new report by Grand View
Research, Inc. Increased prevalence of neurodegenerative, orthopedic, and other
aging-related disorders in geriatric population coupled with rising global
geriatric population is anticipated to drive market growth.
Developments in biotechnology
have enabled gaining in-depth knowledge pertaining to cell division and
differentiation as well as the metabolism mechanism of various cells. This
enriched knowledge, coupled with emergence of novel streams of biotechnology
such as gene therapy and nanotechnology, further prospered use of cell-based
technology in therapeutic treatment.
Well established regenerative
approached for various dermatological indications exists since ages.
Technological advances introduced scaffolds, matrices, and grafts engineered
for faster regeneration and minimal surgical procedure.
UK regenerative medicine market revenue by product type, 2014 - 2025 (USD Million)
Browse full research report on Regenerative Medicine Market
Identification of ability of stem
cells to develop into various different cell lines further propelled the
advancements in regenerative medicine. Frequent media exposure due to
regulatory as well as ethical controversies around embryonic stem cells has
increased awareness among the masses. This encouraged researchers to explore
and develop other potential fields for similar applications, such as induced
pluripotent stem cells (iPSC).
Furthermore, the emergence of
gene therapy techniques with potential to rectify and restore effects of gene
mutations in cells is under development. Conditions caused due to Single
Nucleotide Polymorphism (SNP) as well as mutations that induce degenerative
characteristics are primarily targeted.
Biologics, individually or in
combination with cells or devices, are explored to support regenerate the
biological functions of cells, tissues, or organs. A number of combinatorial therapies
to support chemotherapy and other cancer treatments by prevention as well as
treatment for cancer relapse are in development phases.
In addition, rising prevalence of
complicated degenerative disorders such as age-related macular degeneration,
Alzheimer’s disease, and Parkinson’s disease, especially in the aging
population resulted in high investments in R&D to develop therapeutic
solutions.
Regenerative medicine grabs the
attention of the healthcare industry owing to its promising applications along
with significant advances in supportive fields including tissue engineering,
stem cells, gene therapy, drug discovery and nanotechnology. For instance, 3D
printing over scaffold with stem cells to restore structure as well as
functional characteristics of biological cells, tissues, and organs.
Further key findings from the report suggest:
- The global
regenerative medicine demand exceeded USD 1.7 billion in 2016 and is
expected to grow at a considerable rate over the forecast period owing to
the presence of a strong looking product pipeline with anticipated
commercializations just around the corner
- Therapeutics
emerged as the largest product segment in 2016 as it has a relatively high
implementation and usage rate resulting in higher adoption
- Global
regenerative services demand for facilities such as tissue banks and
cellular engineering tools is expected to drive demand in the segment
- The industry
in Asia Pacific is projected to witness substantial growth over the next
decade owing to various developments across major economies with increased
focus of dominant players in emerging economies is attributive to market
growth. market.
- Key players
including Asterias Bio, Athersys, Integra LifeSciences Corpotation, and
MiMedx are involved in complex technical cum financial partnerships with
larger players in an attempt to expedite R&D
Comments
Post a Comment